PDA offers support as Lloydspharmacy branch sale rumours persist

Pharmacists working at Lloydspharmacy have been reassured by the Pharmacists’ Defence Association (PDA) following speculation that the multiple plans to divest itself of “a number” of branches. 

Lloydspharmacy sale PDA
LloydsPharmacy: "Decision to sell stores is taken in the interests of patients, colleagues and the business"

In a statement, the PDA claimed it had been made aware that “a number of Lloydspharmacy” branches are “currently going through the divestiture process”.

The union said it understands that “such changes of ownership will be of significant concern to individuals who are employed at the pharmacies”.

Lloydspharmacy has not explicitly confirmed whether its is divesting any branches, or how many branches are affected if this is indeed the case.

However, the PDA reassured members that where an existing business is acquired and absorbed into another, existing employees “should not see any major changes to their working arrangements because of the transfer”.

If members are concerned, they should contact the PDA service centre “in the first instance”, it added.

Read more: Lloydspharmacy may sell substantial number of branches, sources tell C+D

“It is better to contact us as questions or concerns emerge, rather than allow the situation to develop before confirming and exercising your rights at work,” the union said.

It comes after several sources told C+D in May of the multiple’s alleged plans to sell a substantial number of branches. At the time, Lloydspharmacy said “no decisions” had been made.

Lloydspharmacy: Patient safety is “top priority”

A spokesperson for Lloydspharmacy told C+D yesterday (November 22) that the multiple “regularly reviews its pharmacy estate to ensure it is operating sustainably”.

“Any decision to sell stores is taken in the interests of patients, colleagues and the business,” they added.

Patient safety “remains our top priority, ensuring our customers and patients are always able to access vital prescriptions, health advice, products and services”, they added.

Read more: McKesson completes sale of Lloydspharmacy to Aurelius Group

In April, private equity firm Aurelius Group completed a £477 million acquisition of McKesson UK, Lloydspharmacy’s parent company.

The group rebranded McKesson UK to Hallo Healthcare in September.

Lloydspharmacy revealed in its financial report for 2020/2021 that it had decided to close, merge, or sell 76 branches in 2020/21 as part of a “rationalisation programme” it started as a consequence of the “challenging” government funding model.

Sign in or register for free

Latest from News

All the headlines: Community pharmacy funding deal

 
• By 
 • comment0

Find out everything you need to know about the government’s plans for community pharmacy – as outlined in this week’s long-awaited pharmacy funding deal.

Pharmacy stop-smoking service expands to ‘non-registered’ staff

 
• By 
 • comment0

The new pharmacy contract has expanded who can deliver the smoking cessation service, as well as adding the provision of two drugs via PGDs.

Revealed: 2024/25 contract cash uplift already paid

 
• By 
 • comment5

Following this week’s announcement of the long-awaited pharmacy funding deal, C+D has learned that contractors have already received the additional £106 million in retrospective funding for 2024/25.

More from Multiples

breaking news

BREAKING: Morrisons to close four pharmacies

 
• By 
 • comment

Supermarket giant Morrisons has revealed plans to close four of its pharmacies following a "wide-ranging review".

Lloydspharmacy: £40m locum tax ‘directly impacts’ £2.6m staff claims

 
• By 
 • comment

Fresh liquidation accounts have revealed that Lloydspharmacy has paid half a million pounds to former owners, but that payments for “non-preferential” creditors are “wholly dependent” on a successful tax appeal.